India's Concord Biotech hits record high
** Shares of Concord Biotech CONB.NS surge as much as
12.6% to a record high of 1,815 rupees; last up 5.4%
** Reuters could not immediately ascertain a reason for the
stock's move
** Biopharma firm eyes busiest session since late-May,
volumes at 28.3x the 30-day avg
** Including session's gains, stock up ~16% YTD
(Reporting by Manvi Pant in Bengaluru)
((Manvi.Pant@thomsonreuters.com; +918447554364;))
Recent news on Concord Biotech
See all newsIndia's Concord Biotech rises after board to consider bonus share issue
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval